| Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: an … L Guidi, D Pugliese, TP Tonucci, A Berrino, B Tolusso, M Basile, ... Journal of Crohn's and Colitis 12 (9), 1079-1088, 2018 | 90 | 2018 |
| Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy M Ruggeri, M Basile, A Zini, S Mangiafico, EC Agostoni, K Lobotesis, ... Journal of medical economics 21 (9), 902-911, 2018 | 37 | 2018 |
| Italian guidelines for the management of non-functioning benign and locally symptomatic thyroid nodules E Papini, A Crescenzi, A D'Amore, M Deandrea, A De Benedictis, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023 | 21 | 2023 |
| Analisi dei modelli organizzativi di risposta al Covid-19 A Cicchetti, G Damiani, ML Specchia, M Basile, R Di Bidino, E Di Brino, ... Alta Scuola di Economia e Management dei Sistemi Sanitari, 2020 | 19 | 2020 |
| Cost-effectiveness analysis of early treatment of chronic HCV with sofosbuvir/velpatasvir in Italy M Ruggeri, F Romano, M Basile, S Coretti, FR Rolli, C Drago, A Cicchetti Applied health economics and health policy 16, 711-722, 2018 | 19 | 2018 |
| Economic analysis and budget impact of tenofovir and entecavir in the first-line treatment of hepatitis B virus in Italy M Ruggeri, M Basile, S Coretti, C Drago, A Cicchetti Applied Health Economics and Health Policy 15, 479-490, 2017 | 15 | 2017 |
| Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy A Fanelli, M Ruggeri, M Basile, A Cicchetti, F Coluzzi, G Della Rocca, ... Minerva Med 107 (1), 1-13, 2016 | 11 | 2016 |
| Cost-effectiveness analysis of lesinurad/allopurinol versus febuxostat for the management of gout/hyperuricemia in Italy M Ruggeri, M Basile, C Drago, FR Rolli, A Cicchetti Pharmacoeconomics 36, 625-636, 2018 | 10 | 2018 |
| Report di approfondimento e valutazione, con metodologia HTA (Health Technology Assessment), della vaccinazione anti-HPV nelle donne trattate per lesioni HPV-correlate GE Calabrò, E Carini, C Favaretti, P Bonanni, R De Vincenzo, A Ghelardi, ... QIJPH 8, 7, 2019 | 8 | 2019 |
| Economic evaluation of Zepatier for the management of HCV in the Italian scenario FR Rolli, M Ruggeri, F Kheiraoui, C Drago, M Basile, C Favaretti, ... The European Journal of Health Economics 19, 1365-1374, 2018 | 8 | 2018 |
| Activity-based costing and budget analysis of vedolizumab versus conventional treatments in ulcerative colitis and Crohn's disease: Analisi Organizzativa e di Budget Dell … M Ruggeri, M Basile, A Armuzzi, A Cicchetti Global and Regional Health Technology Assessment 4 (1), 88-99, 2017 | 8 | 2017 |
| Italian guidelines for the management of prolactinomas R Cozzi, R Simona Auriemma, E De Menis, F Esposito, E Ferrante, G Iatì, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023 | 7 | 2023 |
| HPV vaccination in women treated for cervical intraepithelial neoplasia: a budget impact analysis M Basile, GE Calabrò, A Ghelardi, R Ricciardi, R De Vincenzo, A Cicchetti Vaccines 9 (8), 816, 2021 | 7 | 2021 |
| Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy R Pastorino, M Basile, A Tognetto, M Di Marco, A Grossi, ... Plos one 15 (7), e0235038, 2020 | 6 | 2020 |
| Economic burden of prescriptive inadequacy in the management of osteoarthritis in Italy: Il burden economico dell’inappropriatezza prescrittiva nella gestione dell’osteoartrite … M Basile, F Rumi, M Palmeri, I Mattozzi, L Manzoli, M Mammuccari, ... Global and Regional Health Technology Assessment 7 (1), 101-108, 2020 | 5 | 2020 |
| Analisi Organizzativa e di Budget Dell'introduzione di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa e Morbo di Crohn: Implicazioni Economiche Nel … M Ruggeri, M Basile, A Armuzzi, A Cicchetti Global & Regional Health Technology Assessment 4 (1), grhta. 5000258, 2017 | 5 | 2017 |
| Italian guidelines for the management of sporadic primary hyperparathyroidism F Vescini, G Borretta, I Chiodini, M Boniardi, M Carotti, E Castellano, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2024 | 4 | 2024 |
| Cost-effectiveness and budget impact analysis for high dose quadrivalent influenza vaccine in the Italian elderly population F Rumi, M Basile, A Cicchetti Global and Regional Health Technology Assessment 8 (1), 105-113, 2021 | 4 | 2021 |
| A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas M Basile, I Valentini, R Attanasio, R Cozzi, A Persichetti, I Samperi, ... Global & Regional Health Technology Assessment 11, 1, 2024 | 3 | 2024 |
| EPH264 The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Adults Aged 60 and Older in Italy: Preliminary Results … A Puggina, GE Calabrò, R Santacroce, F Rumi, L Elliot, M Basile, ... Value in Health 26 (12), S251, 2023 | 3 | 2023 |
